
Custom Health Holdings is an AI-enabled healthcare technology company operating an infrastructure platform ensuring medication therapy works as intended.
customhealth.comCrawled Nov 6, 2026
Pharmacist-led clinical oversight that actively manages medication therapy. Continuous monitoring, patient engagement, and provider coordination at scale.
Spencer and PatchCap capture real-world medication data at home, providing clinical visibility and supporting earlier intervention through AdhereNet.
Integrated medication management platform connecting pharmacy, devices, and clinical care. AdhereNet unifies data for pharmacist-led oversight and action.
98% medication adherence, 27% reduction in opioid use, 42% fewer unnecessary medications. Proven outcomes through continuous monitoring and clinical oversight.
Benzinga Highlights Custom Health’s Connected Approach to Medication Management. News and insights from Custom Health (TSX: CHLT).
CEO Shane Bishop Discusses Custom Health’s Growth Strategy and U.S. Expansion. News and insights from Custom Health (TSX: CHLT).
CEO Shane Bishop Discusses Custom Health’s Vision for Connected Care at the 2025 Cantech Investment Conference. News and insights from Custom Health (TSX: CHLT).
Custom Health Achieves 70% Increase in Quarterly Revenue in Q2-2026 and Advances Medication Management Platform with Evergreen Pharmacy and Spencer Health Solutions Acquisitions. News and insights from Custom Health (TSX: CHLT).
Custom Health CEO Shane Bishop Discusses Growth Strategy and TSX Debut with Proactive. News and insights from Custom Health (TSX: CHLT).
Custom Health Enters into Definitive Agreement to Complete Business Combination with Queue Ventures. News and insights from Custom Health (TSX: CHLT).
Custom Health Featured in Cantech Letter Following Stifel Analyst Initiation. News and insights from Custom Health (TSX: CHLT).
Custom Health Holdings Inc. Announces Completion Of Plan Of Arrangement. News and insights from Custom Health (TSX: CHLT).
Custom Health offers careers focused on transforming medication management through technology, pharmacy innovation, and patient-centered care.
Andrew Aertker, VP of Product Strategy & Business Operations at Custom Health, discusses his role in building infrastructure for home medication management.
Brent Herman, EVP of Corporate Development at Custom Health, shares his experience in developing infrastructure for home medication management.
Custom Health’s clinical and pharmacy leaders oversee remote clinical care, quality, analytics, and pharmacy operations for home medication management.
Deborah Cenci, Acting CEO of DIVA Pharmaceuticals at Custom Health, outlines her experience in building infrastructure for home medication management.
Custom Health connects pharmacy, in-home technology, and pharmacist-led clinical oversight to improve medication adherence and outcomes at home.
The page provides contact details for Custom Health’s platform inquiries, patient eligibility, investor relations, and general support.
Custom Health Pharmacy Chilliwack is part of the Custom Health pharmacy network, supporting structured medication management and continuous care at home.
Custom Health Pharmacy Indianapolis is part of the Custom Health pharmacy network, supporting structured medication management and continuous care at home.
Custom Health Pharmacy Langley is part of the Custom Health pharmacy network, supporting structured medication management and continuous care at home.
Custom Health combines pharmacy services, in-home technology, and pharmacist-led care to improve medication adherence and outcomes.
Custom Health Holdings Inc. files its final short form base shelf prospectus with Canadian securities regulators. The prospectus allows the company to raise capital through future equity offerings. The filing follows regulatory approval across all Canadian provinces and territories.
Nov 2026Yahoo FinanceNews article
Custom Health filed a preliminary shelf prospectus to raise up to **$200 million in securities** over 25 months. The company restated its **Q2 2026 financials**, reducing its net loss to **$30.4 million** for the quarter and **$38.9 million** year-to-date after adjustments. The offering remains subject to regulatory approval.
Nov 2026TradingViewNews article
Custom Health Holdings Inc. (CHLT) appoints two new executives to its C-suite leadership team. The company plans to close the Toronto Stock Exchange on October 22, 2026, to mark its recent listing on the TSX Exchange.
Oct 2026TradingViewNews article
Custom Health Holdings reports a 70% year-over-year revenue increase. The company expands its pharmacy partnerships to aim for a $130 million annual revenue run rate. Growth is driven by strategic deals in the pharmacy sector.
Aug 2026Proactiveinvestors NANews article